9 results
8-K
EX-3.2
MRTX
Mirati Therapeutics Inc
23 Jan 24
Contingent Value Rights Agreement
8:48am
8-K
EX-3.1
MRTX
Mirati Therapeutics Inc
23 Jan 24
Contingent Value Rights Agreement
8:48am
DEFA14A
EX-3.2
MRTX
Mirati Therapeutics Inc
10 Oct 23
Additional proxy soliciting materials
7:35am
DEFA14A
EX-3.1
MRTX
Mirati Therapeutics Inc
10 Oct 23
Additional proxy soliciting materials
7:35am
8-K
EX-3.2
MRTX
Mirati Therapeutics Inc
10 Oct 23
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio with Acquisition of Mirati Therapeutics
7:33am
8-K
EX-3.1
jor3z1feqp7b avptv
10 Oct 23
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio with Acquisition of Mirati Therapeutics
7:33am
8-K
EX-3.1
vo36up2bq k6b
16 Jun 16
Amendments to Articles of Incorporation or Bylaws
12:00am
10-12B
EX-3.2
taof4m8fw0lx4jef67
10 May 13
Registration of securities
12:00am
10-12B
EX-3.1
689hbx
10 May 13
Registration of securities
12:00am
- Prev
- 1
- Next